Solex Energy Q1 FY27 Revenue Up 1.8% to INR 265.6 Cr, PAT at INR 8.3 Cr

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Solex Energy Q1 FY27 Revenue Up 1.8% to INR 265.6 Cr, PAT at INR 8.3 Cr

Solex Energy reported a 1.8% revenue increase to INR 265.6 crore for Q1 FY27. While EBITDA dipped 20.8%, the company posted a Profit After Tax (PAT) of INR 8.3 crore. Management cited seasonal factors and increased finance costs impacting margins.

Solex Energy Q1 FY27 Results Analysis

Solex Energy's Q1 FY27 revenue grew 1.8% to INR 265.6 crore, compared to INR 261.0 crore in Q1 FY26. Profit After Tax (PAT) was INR 8.3 crore, with a PAT margin of 3.1%. Earnings Per Share (EPS) stood at INR 7.39.

Reader Takeaway: Revenue growth amid margin pressure; future growth hinges on cell capex and order execution.

What just happened

Solex Energy reported Q1 FY27 financial results showing a modest revenue increase. However, EBITDA saw a significant decline of 20.8% to INR 33.8 crore from INR 42.7 crore in the previous year. This led to a compression in EBITDA margin to 12.7% from 16.4%.
The company attributed the EBITDA margin decline to the full-quarter impact of depreciation and finance costs on its recently expanded 4 GW module manufacturing capacity. Finance costs nearly doubled to INR 12.5 crore from INR 5.4 crore, due to higher working capital needs for expanded operations.

Why this matters

The results highlight the impact of increased operational costs and financing on profitability, even with revenue growth. The company's performance in the first quarter is traditionally lower due to its business model, which is heavily weighted towards the second half of the financial year for utility-scale solar project execution. Shareholders are looking for signs of a strong second half and progress on strategic growth initiatives.

The backstory

Solex Energy has been investing in expanding its manufacturing capacity, including a 4 GW module manufacturing facility commissioned in late FY26. This expansion, while setting the stage for future growth, has increased fixed costs such as depreciation and finance expenses. The company's business is cyclical, with a focus on H2 execution.

What changes now

Management has revised its cell manufacturing capex plan downwards to INR 1,050 crore from INR 1,500 crore, removing planned module capacity expansion. The focus is now on a 5 GW cell capacity project, with the first phase of 2.2 GW expected by end-2027. The company also plans to explore Battery Energy Storage System (BESS) opportunities through a separate subsidiary.

The company is working with a conservative 55% utilization assumption for its 4 GW module capacity in FY27. Guidance for FY27 PAT margin is set between 5% and 6%.

Risks to watch

Key risks include the execution of the order book by December 31, 2026, particularly the INR 845.84 crore executable pipeline. Progress on financing and land documentation for the 5 GW cell manufacturing facility is crucial. Market uncertainties, such as ALMM (ALCM-2), continue to influence customer decision-making, although management views this as a timing issue.

Peer comparison

Solex Energy operates in the solar energy sector, which is competitive. Companies in this space often face challenges related to raw material costs, government policies, and the cyclical nature of project execution. Specific peer data was not provided in the filing.

Context metrics (time-bound)

The executable order pipeline by December 31, 2026, is INR 845.84 crore. The order book visibility is approximately INR 3,400 crore, comprising confirmed orders, MSAs, and advanced discussions.

What to track next

Investors will be closely watching the company's ability to execute its order book, particularly the INR 845.84 crore pipeline. Progress on the INR 1,050 crore cell manufacturing capex and the exploration of BESS opportunities will also be key indicators of future growth. Management's guidance on the 5% to 6% PAT margin for FY27 will be important to monitor.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.